ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the inter...

Contract development and manufacturing organisation (CDMO) Recipharm has appointed Bernard Pluta to lead its new global development organisation. The newly establishe...

The biohub will be a joint venture between TUS and Trinity College, Cambridge, the owner of the park. Tsinghua University Holdings (TUS) of Beijing is planning to in...

£1 million awarded to develop innovations for earlier and faster diagnosis Cancer survival rates in England are at an all-time high with over 7000 more people survivi...

SAB will provide scientific oversight and strategic advice to support Metrion’s ion channel screening, cardiac safety testing, and native tissue and human stem cell t...

Funding for preclinical research with the view to applying for clinical trial authorisation for first drug candidate in new class of antibiotics Nosopharm, a company ...

This designation has been awarded for the treatment of AMHR2-expressing ovarian cancers, exclusive of AMHR2-expressing fallopian tube cancers and primary peritoneal c...